Provider
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Program effective Date: Feb 08, 2023
Program effective Date: Feb 08, 2023
Program effective Date: Feb 08, 2023
Quantity Limit
Program effective Date: Apr 01, 2025
Program effective Date: Feb 01, 2023
Program effective Date: Feb 22, 2023
Program effective Date: Feb 22, 2023
Program effective Date: Feb 22, 2023
Quantity Limit
Program effective Date: Apr 01, 2025
Quantity Limit
Program effective Date: Apr 01, 2025